TCTC Holdings’s AstraZeneca AZN Stock Holding History

TCTC Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150	Closed	-$27.6K	–	248
2025 Q4	$27.6K	Hold	150	–	–	﹤0.01%	414
2025 Q3	$23K	Hold	150	–	–	﹤0.01%	426
2025 Q2	$21K	Hold	150	–	–	﹤0.01%	456
2025 Q1	$22.1K	Hold	150	–	–	﹤0.01%	453
2024 Q4	$19.7K	Hold	150	–	–	﹤0.01%	428
2024 Q3	$23.4K	Hold	150	–	–	﹤0.01%	385
2024 Q2	$23.4K	Hold	150	–	–	﹤0.01%	392
2024 Q1	$20.3K	Hold	150	–	–	﹤0.01%	385
2023 Q4	$20.2K	Hold	150	–	–	﹤0.01%	373
2023 Q3	$20.3K	Hold	150	–	–	﹤0.01%	321
2023 Q2	$21.5K	Hold	150	–	–	﹤0.01%	318
2023 Q1	$20.8K	Hold	150	–	–	﹤0.01%	343
2022 Q4	$20.3K	Hold	150	–	–	﹤0.01%	331
2022 Q3	$16K	Hold	150	–	–	﹤0.01%	327
2022 Q2	$20K	Hold	150	–	–	﹤0.01%	318
2022 Q1	$20K	Hold	150	–	–	﹤0.01%	331
2021 Q4	$17K	Hold	150	–	–	﹤0.01%	373
2021 Q3	$18K	Hold	150	–	–	﹤0.01%	378
2021 Q2	$18K	Hold	150	–	–	﹤0.01%	343
2021 Q1	$15K	Sell	150 -150	-50%	-$15.1K	﹤0.01%	345
2020 Q4	$30K	Hold	300	–	–	﹤0.01%	282
2020 Q3	$33K	Hold	300	–	–	﹤0.01%	267
2020 Q2	$32K	Buy	+300	New	+$31K	﹤0.01%	269

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

TCTC Holdings's AZN Position: Q1 2026 in Review

TCTC Holdings sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 150 shares — an estimated $27.6K sold.

TCTC Holdings first reported a position in AZN in Q2 2020 and held it in 23 quarters. The position peaked at $33K in Q3 2020. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

TCTC Holdings reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
TCTC Holdings sold 150 AstraZeneca shares in Q1 2026, an estimated $27.6K.
TCTC Holdings first reported a position in AstraZeneca in Q2 2020 and held it in 23 quarters.
TCTC Holdings's AstraZeneca position peaked at $33K in Q3 2020.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.